Watch Ticker

Vericel Corporation

Go to Vericel Corporation Website

$36.82

0.00 (0.00%)

Live

Previous Close

$36.82

Day Range

$0 - $0

Previous Day Range

$36.3901 - $37.64

Market Cap

$1.9 billion USD

Day Vol.

Previous Day Vol.

489420

Currency

USD

Primary Exchange

Nasdaq

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondroc...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Jesterai - Vericel Q2 Revenue Jumps 20%

Vericel reported Q2 2025 revenue growth of 20% to $63.2 million, driven by strong MACI cartilage repair franchise performance. The company expanded gross margins to 74% and narrowed net loss per share, while preparing for potential market expansion into ankle cartilage repair.

Related tickers: VCEL.

Read Full Article

Vericel Corporation - Vericel Reports Second Quarter 2024 Financial Results

Vericel Corporation reported strong financial results for the second quarter of 2024, with record revenue, MACI revenue growth, and significant margin expansion. The company also provided an update on the progress of its NexoBrid launch and raised its full-year profitability guidance.

Related tickers: VCEL.

Read Full Article

Trending Tickers

Please sign in to view